The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma

The effect of Bortezomib and Rapamycin on Telomerase Activity in Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is a hematological malignancy with unfavorable prognosis. Novel therapeutic approaches for treating the disease are aimed at the mechanisms regulating growth signals, cellular proliferation, and survival pathways of the malignant clones. Bortezomib (Brt), a proteasome inhi...

Full description

Bibliographic Details
Main Authors:	Orit Uziel, Olga Cohen, Einat Beery, Jardena Nordenberg, Meir Lahav
Format:	Article
Language:	English
Published:	Elsevier 2014-12-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523314000977

Similar Items

Exosomal telomerase transcripts reprogram the microRNA transcriptome profile of fibroblasts and partially contribute to CAF formation
by: Daniela Likonen, et al.
Published: (2022-09-01)

Identification of Cancer Cells in the Human Body by Anti-Telomerase Peptide Antibody: Towards the Isolation of Circulating Tumor Cells
by: Olga Karpov, et al.
Published: (2022-10-01)

The Effect of Ethanol on Telomere Dynamics and Regulation in Human Cells
by: Tomer Harpaz, et al.
Published: (2018-10-01)

Bortezomib in mantle cell lymphoma: comparative therapeutic outcomes
by: Vallumsetla N, et al.
Published: (2015-11-01)

Proteomic and microRNA data clarifying the effects of telomere shortening on cancer cells
by: Orit Uziel, et al.
Published: (2015-03-01)

Telomere shortening sensitizes cancer cells to selected cytotoxic agents: in vitro and in vivo studies and putative mechanisms.
by: Orit Uziel, et al.
Published: (2010-01-01)

3-Methyladenine but not antioxidants to overcome BACH2-mediated bortezomib resistance in mantle cell lymphoma
by: Min Feng, et al.
Published: (2021-05-01)

PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
by: Junghoon Shin, et al.
Published: (2023-08-01)

Effects of the Proteasome Inhibitor Bortezomib in Combination with Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-analysis
by: Shi-jun Li, et al.
Published: (2020-02-01)

Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth
by: Fu-Lian Qu, et al.
Published: (2015-12-01)

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
by: Simon Heine, et al.
Published: (2018-09-01)

Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma
by: Grégoire Quinet, et al.
Published: (2022-02-01)

Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma
by: Fabrizio Huwyler, et al.
Published: (2023-03-01)

Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma
by: Sudjit Luanpitpong, et al.
Published: (2022-11-01)

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
by: Wang Cun, et al.
Published: (2012-05-01)

Cytogenetics of mantle cell lymphoma
by: T N Obukhova, et al.
Published: (2004-07-01)

Deciphering the Elevated Lipid via CD36 in Mantle Cell Lymphoma with Bortezomib Resistance Using Synchrotron-Based Fourier Transform Infrared Spectroscopy of Single Cells
by: Sudjit Luanpitpong, et al.
Published: (2019-04-01)

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation
by: Robert W. Chen, et al.
Published: (2018-06-01)

Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma
by: Fumiko Arakawa, et al.
Published: (2021-10-01)

Blocking Mammalian Target of Rapamycin (mTOR) Alleviates Neuropathic Pain Induced by Chemotherapeutic Bortezomib
by: Zongsheng Duan, et al.
Published: (2018-07-01)

Differences in Telomere Length between Adolescent Females with Anorexia Nervosa Restricting Type and Anorexia Nervosa Binge-Purge Type
by: Orit Uziel, et al.
Published: (2023-06-01)

CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
by: Razan Mohty, et al.
Published: (2022-12-01)

Tackling Mantle Cell Lymphoma in Europe
by: Denis Horgan, et al.
Published: (2022-09-01)

Primary gastric mantle cell lymphoma
by: Duska Petranovic, et al.
Published: (2012-01-01)

Educational Case: Mantle Cell Lymphoma
by: Brenda Mai MD, et al.
Published: (2020-07-01)

Diagnosis and treatment of mantle cell lymphoma
by: Felicitas Hitz, et al.
Published: (2013-11-01)

Emerging therapies in mantle cell lymphoma
by: Walter Hanel, et al.
Published: (2020-06-01)

Mantle Cell Lymphoma Case Report
by: V.I. Podzolkov, et al.
Published: (2018-12-01)

cutaneous manifestation of mantle cell lymphoma
by: avinash kumar singh, et al.
Published: (2014-08-01)

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study
by: Lucia Morello, et al.
Published: (2020-02-01)

Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy
by: Ofer Rotem, et al.
Published: (2023-06-01)

Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma
by: Juliana Carvalho Santos, et al.
Published: (2022-11-01)

Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib.
by: Shringarpure, R, et al.
Published: (2006)

Maintenance Treatment for Patients With Mantle Cell Lymphoma
by: Liat Vidal, et al.
Published: (2018-08-01)

Management of Drug Resistance in Mantle Cell Lymphoma
by: Gaël Roué, et al.
Published: (2020-06-01)

Atypical cytologic mantle cell lymphoma presentation
by: Mathias Chea, et al.
Published: (2022-08-01)

Chylous Ascites due to Mantle Cell Lymphoma
by: Ricardo Jorge Gonçalves Fernandes, et al.
Published: (2018-04-01)

Mantle Cell Lymphoma Involving Gastrointestinal Tract
by: Seol So, et al.
Published: (2018-02-01)

Morphological spectrum of leukemic mantle cell lymphoma
by: Khaliqur Rahman, et al.
Published: (2012-01-01)

Management of mantle cell lymphoma in the elderly patient
by: Doorduijn JK, et al.
Published: (2013-09-01)